Serial Number | 97069693 |
Word Mark | FROM NEUTRON TO PATIENT |
Filing Date | Tuesday, October 12, 2021 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Wednesday, April 3, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 28, 2023 |
Goods and Services | Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals |
Goods and Services | Pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 2, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 2, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | POINT Biopharma USA Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46268 |
Party Name | POINT Biopharma USA Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46268 |
Event Date | Event Description |
Tuesday, June 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, October 15, 2021 | NEW APPLICATION ENTERED |
Tuesday, November 2, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, June 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, June 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, July 18, 2022 | ASSIGNED TO EXAMINER |
Friday, July 22, 2022 | NON-FINAL ACTION WRITTEN |
Friday, July 22, 2022 | NON-FINAL ACTION E-MAILED |
Friday, July 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, January 23, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 23, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, January 26, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, February 28, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, February 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, February 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, March 12, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, October 25, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, October 25, 2023 | SOU EXTENSION 1 FILED |
Wednesday, October 25, 2023 | SOU EXTENSION 1 GRANTED |
Friday, October 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, March 12, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, March 12, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, April 3, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, April 3, 2024 | SOU EXTENSION 2 FILED |
Wednesday, April 3, 2024 | SOU EXTENSION 2 GRANTED |
Thursday, April 4, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |